why choose us

First received: December 13, 2022

Clinical Trial: Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Soft Tissue Sarcoma

Study Type: INTERVENTIONAL


Official Title: ADI-PEG 20 or Placebo Plus Gemcitabine and Docetaxel in Previously Treated Subjects With Leiomyosarcoma (ARGSARC): A Randomized, Double Blind, Multi-Center Phase 3 Trial

Brief Summary: To compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.

Read more